[1]翟瑶瑶,王 成,郭晓梅,等.活血通脉稳斑汤联合增强型体外反搏治疗冠心病不稳定型心绞痛痰阻心脉证疗效[J].陕西中医,2023,(11):1573-1576.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.018]
　ZHAI Yaoyao,WANG Cheng,GUO Xiaomei,et al.Effect of Huoxue Tongmai Wenban decoction combined with enhanced external counterpulsation in treatment of unstable angina of coronary heart disease with Tanzu Xinmai syndrome[J].,2023,(11):1573-1576.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.018]
点击复制

活血通脉稳斑汤联合增强型体外反搏治疗冠心病不稳定型心绞痛痰阻心脉证疗效
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年11期
页码:
1573-1576
栏目:
临床研究
出版日期:
2023-11-05

文章信息/Info

Title:
Effect of Huoxue Tongmai Wenban decoction combined with enhanced external counterpulsation in treatment of unstable angina of coronary heart disease with Tanzu Xinmai syndrome
作者:
翟瑶瑶; 王 成; 郭晓梅; 刘艳军
(秦皇岛市中医医院心血管科,河北 秦皇岛 066000)
Author(s):
ZHAI Yaoyao; WANG Cheng; GUO Xiaomei; LIU Yanjun
(Department of Cardiovascular Medicine,Qinhuangdao Hospital of Traditional Chinese Medicine,Qinhuangdao 066000,China)
关键词:
冠心病不稳定型心绞痛;  活血通脉稳斑汤;  增强型体外反搏;  心功能;  血液流变学;  血管内皮功能
Keywords:
Unstable angina of coronary heart disease;  Huoxue Tongmai Wenban decoction;  Enhanced external counterpulsation;  Cardiac function;  Hemorheology;  Vascular endothelial function
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7369.2023.11.018
文献标志码:
A
摘要:
目的:探究活血通脉稳斑汤联合增强型体外反搏(EECP)治疗冠心病不稳定型心绞痛痰阻心脉证临床效果。方法:选取112例冠心病不稳定型心绞痛痰阻心脉证患者为研究对象,采用单双球法随机分为对照组、联合组,各56例。对照组给予EECP治疗,联合组给予活血通脉稳斑汤联合EECP治疗。比较两组治疗前、治疗4周后中医证候积分、心功能、血液流变学、血管内皮功能,记录两组患者治疗期间不良反应发生率。结果:治疗4周后,两组患者中医证候积分、纤维蛋白原、红细胞沉降率、全血黏度、血细胞比容、血栓素B2(TXB2)、内皮素-1(ET-1)水平降低,联合组低于对照组(均P<0.05)。治疗后,两组心排量、每搏输出量、二尖瓣口舒张早期血流速度峰值/左心房舒张晚期血流速度峰值、左心室射血分数、血管内皮生长因子、一氧化氮水平升高,且联合组高于对照组(均P<0.05)。治疗期间,联合组不良反应发生率为3.57%,对照组为5.36%,差异无统计学意义(P>0.05)。结论:活血通脉稳斑汤联合EECP可有效改善冠心病不稳定型心绞痛痰阻心脉证症状,增强患者心功能,改善血液流变学、血管内皮功能,且不增加不良反应。
Abstract:
Objective:To explore effect of Huoxue Tongmai Wenban decoction combined with enhanced external counterpulsation(EECP)in treatment of unstable angina of coronary(UA)heart disease with Tanzu Xinmai syndrome.Methods:112 patients with UA Tanzu Xinmai admitted as research subjects were randomly divided into control group and combined group,56 cases in each group,by single-double ball method.The control group were given EECP,and the combined group treated with Huoxue Tongmai Wenban decoction combined with EECP.Before treatment and after 4 weeks of treatment,the TCM syndromes scores,cardiac function,hemorheology and vascular endothelial function were compared between the two groups.The incidence rates of adverse reactions during treatment were recorded in the two groups.Results:After 4 weeks of treatment,the TCM syndromes scores,fibrinogen,erythrocyte sedimentation rate,whole blood viscosity,hematocrit,TXB2,ET-1 in both groups were decreased,and the above indicators in the combined group were lower than those in the control group(all P<0.05).After treatment,CO,SV,E/A,LVEF,VEGF,NO in the two groups were enhanced,and the indicators were higher in the combined group than those in the control group(all P<0.05).During treatment,the toal incidence rate of adverse reactions was 3.57% in the combined group and 5.36% in the control group,difference not statistically significant(P>0.05).Conclusion:Huoxue Tongmai Wenban decoction combined with EECP can effectively improve the symptoms of unstable angina of coronary heart disease of Tanzu Xinmai syndrome,enhance the cardiac function,promote hemorheology and vascular endothelial function.It does not increase adverse reactions.

参考文献/References:

[1] 朱 婷,方蔓倩,蒋海平.三参舒心汤治疗冠心病不稳定性心绞痛疗效及对血清CysC、冠心病不稳定型心绞痛痰阻心脉证、AIP水平的影响[J].四川中医,2022,40(9):102-106.
[2] 刘 宁,艾 英,刘 健.芦黄颗粒联合单硝酸异山梨酯治疗冠心病不稳定型心绞痛疗效及对患者心功能与脂代谢的影响[J].陕西中医,2023,44(1):64-67.
[3] 杜 倩,郑蛟东.化痰祛瘀通脉汤加减治疗冠心病不稳定型心绞痛患者的疗效及其对心肌酶谱、血清基质金属蛋白酶9、可溶性细胞间黏附因子-1水平的影响[J].世界中西医结合杂志,2021,16(12):2255-2260.
[4] 陈 静,王晓燕.瓜蒌夏苓汤治疗冠心病稳定型心绞痛痰阻心脉证的临床疗效及中医症候的影响[J].贵州医药,2021,45(10):1533-1534.
[5] 贾凯侠,夏旭东,田 心.体外反搏治疗急性心肌梗死临床疗效及对患者尿微量白蛋白影响研究[J].陕西医学杂志,2020,49(1):90-92.
[6] 梁海涛,孔倩文,蔺建国,等.通脉稳斑汤对老年冠心病患者PCI术后半年内血管内超声参数和斑块性质的影响[J].四川中医,2021,39(12):74-76.
[7] 中华心血管病杂志编辑委员会.不稳定性心绞痛诊断和治疗建议中华医学会心血管病学分会[J].中华心血管病杂志,2000,28(6):409-412.
[8] 国家中医药管理局.中医病证诊断疗效标准[M].北京:中国中医药出版社,2007:29-30.
[9] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:68-73.
[10] 谭忠伦.加味益气降浊汤联合丹红注射液对冠心病不稳定型心绞痛痰阻心脉证患者心电图变化以及血清TIMP-1、sICAM-1水平变化的影响[J].中国医药导刊,2019,21(2):90-94.
[11] 刘 洪,宫丽鸿.稳斑汤联合增强型体外反搏干预冠心病PCI术后的疗效及对血清SOD、MDA的影响[J].中西医结合心脑血管病杂志,2020,18(5):789-791.
[12] 梁文华,周 炜,石纠纠,等.芪蛭三七汤治疗气虚痰瘀阻络型不稳定型心绞痛患者的疗效及作用机制研究[J].现代生物医学进展,2020,20(12):2396-2400.
[13] 李小莉,王 毅,吴金花.芪蛭三七汤治疗冠心病稳定型心绞痛气虚血瘀证的疗效及对患者凝血功能和心功能的影响[J].血栓与止血学,2021,27(3):385-386,389.
[14] 姜积军,陈 静,徐永康,等.益肾活血汤对老年冠心病不稳定型心绞痛患者血管内皮功能及和肽素的影响[J].中国中医急症,2021,30(12):2189-2191.
[15] 王 娜,杨 琳.薤白通脉汤加减对冠心病不稳定型心绞痛患者中医证候积分及血清VEGF、Hcy水平的干预作用[J].陕西中医,2020,41(10):1388-1391.
[16] 王晓芳,蒙 婷,马 伶.丹参多酚注射液联合尼可地尔治疗冠心病不稳定型心绞痛(痰瘀互结型)临床疗效及对血清学指标的影响[J].湖北中医药大学学报,2021,23(1):18-21.
[17] 杨 静,侯 莉,张 格.自拟活血通脉汤辅助治疗冠心病不稳定型心绞痛疗效观察[J].中国中医急症,2021,30(7):1260-1262.
[18] 张 秋,张 泽.生脉活血汤联合单硝酸异山梨酯对冠心病不稳定型心绞痛血液流变学、心功能及疗效的影响[J].辽宁中医杂志,2021,48(3):99-102.
[19] 莫霄云,杨 朔,黄 琛,等.基于网络药理学探究三七-扶芳藤药对治疗心力衰竭的作用机制[J].中西医结合心脑血管病杂志,2021,19(11):1802-1809.
[20] 马建福,王 豆,陈 灼,等.水蛭治疗缺血性脑卒中药理机制研究进展[J].辽宁中医药大学学报,2022,24(7):79-82.
[21] 孔祥琳,吕 琴,李运伦,等.黄芪甲苷对心脑血管疾病的现代药理作用研究进展[J].中国实验方剂学杂志,2021,27(2):218-223.

相似文献/References:

[1]刘 健,加拉力丁·买买提,董新玲,等.益气活血方治疗冠心病不稳定型心绞痛临床研究[J].陕西中医,2021,(8):1037.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.012]
　LIU Jian,GALALIDIN Maimat,DONG Xinling,et al.Therapeutic effect of Yiqi Huoxie decoction in treating coronary heart disease and its effect on patients' serum sICAM-1,ET and NO[J].,2021,(11):1037.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.012]
[2]刘 宁,艾 英,刘 健.芦黄颗粒联合单硝酸异山梨酯治疗冠心病不稳定型心绞痛疗效及对患者心功能与脂代谢的影响[J].陕西中医,2023,(1):64.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.015]
　LIU Ning,AI Ying,LIU Jian.Effects of Luhuang granule combined with isosorbide mononitrate on cardiac function and lipid metabolism in treatment of unstable angina pectoris of coronary heart disease[J].,2023,(11):64.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.015]

备注/Memo

备注/Memo:
基金项目:河北省秦皇岛市科学技术研究与发展课题(201902A112)
更新日期/Last Update: 2023-11-09